Search filters

Interim results of an ongoing Phase I, dose escalation study of MGA271 (Fc-optimized humanized anti-B7-H3 monoclonal antibody) in patients with refractory B7-H3-expressing neoplasms or neoplasms whose vasculature expresses B7-H3.

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published on 4 November 2015
Author/s

author: Antoni Ribas  Keith Flaherty  Bartosz Chmielowski 

Publication date November 4, 2015
Language
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item